Poster Session D - Tuesday Morning
Category: Liver
R. Todd Frederick, MD
Fellowship Director
California Pacific Medical Center
San Francisco, CA
Parameter | Infection | LVP and/or | GIB | No Identifiable Precipitant | ||||||||
TERLI (n=59) | PBO (n=44) | P Value* | TERLI (n=83) | PBO (n=59) | P Value* | TERLI (n=19) | PBO (n=16) | P Value* | TERLI (n=177) | PBO (n=107) | P Value* | |
HRS Reversal† | 24 (41) | 8 (18) | .018 | 30 (36) | 11 (19) | .025 | 4 (21) | 1 (6) | .347 | 61 (35) | 17 (16) | < .001 |
HRS Reversal without RRT through Day 30‡ | 21 (36) | 6 (14) | .014 | 26 (31) | 10 (17) | .077 | 3 (16) | 0 | .234 | 54 (31) | 17 (16) | .007 |